Antibody binding to native cytomegalovirus glycoprotein B predicts vaccine efficacy

Human cytomegalovirus (CMV) is the most common infectious cause of infant brain damage and post-transplant complications worldwide. Despite the high global burden of disease, vaccine development to prevent infection remains hampered by challenges in generating protective immunity. The most efficacio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Transl Med
Autors principals: Jenks, Jennifer A., Nelson, Cody S., Roark, Hunter K., Goodwin, Matthew L., Pass, Robert F., Bernstein, David I., Walter, Emmanuel B., Edwards, Kathryn M., Wang, Dai, Fu, Tong-Ming, An, Zhiqiang, Chan, Cliburn, Permar, Sallie R.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8058742/
https://ncbi.nlm.nih.gov/pubmed/33148624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.abb3611
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars